PIK3CB c.907G>T ;(p.A303S)

Variant ID: 3-138453541-C-A

NM_006219.2(PIK3CB):c.907G>T;(p.A303S)

This variant was identified in 1 publication

View GRCh38 version.




Publications:


Olaparib is effective in combination with, and as maintenance therapy after, first-line endocrine therapy in prostate cancer cells.

Molecular Oncology
Feiersinger, Gertrud E GE; Trattnig, Kristina K; Leitner, Peter D PD; Guggenberger, Fabian F; Oberhuber, Alexander A; Peer, Sarah S; Hermann, Martin M; Skvortsova, Ira I; Vrbkova, Jana J; Bouchal, Jan J; Culig, Zoran Z; Santer, Frédéric R FR
Publication Date: 2018-04

Variant appearance in text: PIK3CB: 907G>T; A303S
PubMed Link: 29465803
Variant Present in the following documents:
  • MOL2-12-561-s006.xlsx, sheet 7
View BVdb publication page